Peter Vaupel Selected Research

Angiosarcoma of the breast

11/2021	Comment on Kronenfeld et al. Clinical Outcomes for Primary and Radiation-Associated Angiosarcoma of the Breast with Multimodal Treatment: Long-Term Survival Is Achievable. Cancers 2021, 13, 3814.
8/2021	Radiation-Associated Angiosarcoma of the Breast and Chest Wall Treated with Thermography-Controlled, Contactless wIRA-Hyperthermia and Hypofractionated Re-Irradiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Vaupel Research Topics

Disease

96	Neoplasms (Cancer) 01/2022 - 01/2002
65	Hypoxia (Hypoxemia) 03/2022 - 12/2002
13	Hyperthermia 08/2021 - 01/2003
11	Anemia 03/2008 - 12/2002
10	Sarcoma (Soft Tissue Sarcoma) 03/2016 - 01/2002
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 08/2004
8	Acidosis 01/2021 - 07/2004
8	Hyperoxia 05/2016 - 01/2002
7	Breast Neoplasms (Breast Cancer) 10/2020 - 06/2002
6	Carcinoma (Carcinomatosis) 01/2017 - 12/2002
6	Glioblastoma (Glioblastoma Multiforme) 01/2016 - 09/2003
4	Squamous Cell Carcinoma of Head and Neck 03/2022 - 11/2016
4	Leiomyoma (Uterine Fibroids) 01/2011 - 06/2008
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2005 - 07/2003
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 03/2004
3	Neoplasm Metastasis (Metastasis) 01/2020 - 07/2004
2	Angiosarcoma of the breast 11/2021 - 08/2021
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 09/2012
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 04/2019
2	Astrocytoma (Pilocytic Astrocytoma) 08/2015 - 10/2012
2	Urinary Bladder Neoplasms (Bladder Cancer) 11/2007 - 09/2005
2	Genomic Instability 07/2004 - 07/2003
1	Residual Neoplasm 03/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022

Drug/Important Bio-Agent (IBA)

30	Oxygen (Dioxygen)IBA 01/2022 - 01/2002
13	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2003
12	Hemoglobins (Hemoglobin)IBA 09/2012 - 06/2002
9	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 07/2004
9	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2003
7	fluoromisonidazoleIBA 03/2022 - 06/2011
7	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2021 - 10/2006
7	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2003
7	pimonidazoleIBA 01/2017 - 10/2005
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2022 - 09/2005
6	Biomarkers (Surrogate Marker)IBA 03/2022 - 06/2007
6	Adenosine (Adenocard)FDA LinkGeneric 12/2020 - 11/2015
6	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 10/2014 - 01/2008
6	Erythropoietin FDA Link 02/2006 - 04/2003
4	EnzymesIBA 01/2021 - 03/2015
4	NucleotidesIBA 01/2021 - 01/2016
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2005
4	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 12/2020 - 01/2016
4	ProteomeIBA 01/2016 - 07/2004
4	Biological ProductsIBA 10/2014 - 11/2003
4	Carbonic Anhydrase IXIBA 06/2008 - 10/2005
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2016
3	CytokinesIBA 01/2020 - 01/2011
3	Indicators and Reagents (Reagents)IBA 01/2013 - 07/2003
3	Transcription Factors (Transcription Factor)IBA 10/2012 - 01/2004
3	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 10/2011 - 04/2011
2	SirtuinsIBA 01/2021 - 01/2021
2	Bicarbonates (Hydrogen Carbonate)IBA 01/2021 - 01/2008
2	HexosaminesIBA 01/2021 - 01/2021
2	LipidsIBA 01/2021 - 01/2021
2	Pyruvic Acid (Pyruvate)IBA 01/2021 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2020
2	Immune Checkpoint InhibitorsIBA 12/2020 - 01/2020
2	Sirolimus (Rapamycin)FDA Link 01/2020 - 01/2017
2	PhosphatidylserinesIBA 01/2020 - 01/2017
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 04/2019 - 12/2003
2	IonsIBA 01/2017 - 01/2008
2	Epidermal Growth Factor (EGF)IBA 11/2016 - 09/2005
2	carbogenIBA 03/2016 - 11/2015
2	ElementsIBA 10/2012 - 01/2011
2	TransketolaseIBA 01/2011 - 08/2010
2	IsoenzymesIBA 08/2010 - 10/2006
2	Xanthine OxidaseIBA 01/2009 - 10/2007
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2007 - 07/2004
2	alpha-Tocopherol FDA Link 10/2007 - 01/2005
2	Pharmaceutical PreparationsIBA 01/2007 - 10/2006
2	Hypoxia-Inducible Factor 1IBA 10/2006 - 01/2004
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 06/2004 - 12/2003
2	DNA (Deoxyribonucleic Acid)IBA 12/2003 - 07/2003
1	Galectin 3 (LGALS3)IBA 03/2022
1	Blood Proteins (Serum Proteins)IBA 03/2022
1	OsteopontinIBA 03/2022
1	Connective Tissue Growth FactorIBA 03/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Apoptosis Regulatory ProteinsIBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	LigandsIBA 01/2021
1	Protons (Proton)IBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	SymportersIBA 01/2021
1	Essential Amino AcidsIBA 01/2021
1	TensinsIBA 01/2021

Therapy/Procedure

31	Therapeutics 01/2022 - 07/2004
20	Radiotherapy 03/2022 - 09/2003
10	Drug Therapy (Chemotherapy) 01/2017 - 01/2005
8	Electrodes (Electrode) 03/2016 - 12/2002
5	Lasers (Laser) 03/2016 - 01/2002
4	Re-Irradiation 08/2021 - 03/2017
3	Chemoradiotherapy 01/2020 - 08/2015
3	Induced Hyperthermia (Thermotherapy) 01/2019 - 01/2003
3	Catheters 03/2016 - 01/2003
3	Photochemotherapy (Photodynamic Therapy) 01/2005 - 12/2003
2	Neoadjuvant Therapy 10/2017 - 01/2016
2	Aftercare (After-Treatment) 06/2004 - 12/2003
1	Combined Modality Therapy 11/2021